Radiofrequency energy ablation of Barrett's esophagus: the best is yet to come!

Gastrointestinal Endoscopy

Volumn 65, Issue 2, 2007, Pages 200-202

  Bergman, Jacques J G H M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARGON PLASMA COAGULATION; BALLOON CATHETER; BARRETT ESOPHAGUS; DYSPHAGIA; EDITORIAL; ELECTRODE; ENDOSCOPIC MUCOSAL RESECTION; ESOPHAGUS BIOPSY; ESOPHAGUS STENOSIS; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; INTESTINE METAPLASIA; MONEY; OUTPATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOFREQUENCY ABLATION;

BARRETT ESOPHAGUS; BIOPSY; CATHETER ABLATION; ESOPHAGOSCOPY; ESOPHAGUS; HUMANS;

EID: 33846413922     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2006.12.021     Document Type: Editorial

References (14)

1. Sharma V.K., Wang K.K., Overholt B.F., et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 65 (2007) 185-195
2. Ganz R.A., Utley D.S., Stern R.A., et al. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest Endosc 60 (2004) 1002-1010
3. Pereira-Lima J.C., Busnello J.V., Saul C., et al. High power setting argon plasma coagulation for the eradication of Barrett's esophagus. Am J Gastroenterol 95 (2000) 1661-1668
4. Overholt B.F., Lightdale C.J., Wang K.K., et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 62 (2005) 488-498
5. Peters F.P., Kara M.A., Rosmolen W.D., et al. Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study. Am J Gastroenterol 101 (2006) 1449-1457
6. Berenson M.M., Johnson T.D., Markowitz N.R., et al. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology 104 (1993) 1686-1691
7. Van Laethem J.L., Peny M.O., Salmon I., et al. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut 46 (2000) 574-577
8. Overholt B.F., Panjehpour M., and Haydek J.M. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 49 (1999) 1-7
9. Bergman J.J., and Fockens P. Ablating Barrett's metaplastic epithelium: are the techniques ready for clinical use?. Gut 55 (2006) 1222-1223
10. Sampliner R.E. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 93 (1998) 1028-1032
11. Arguedas M.R., and Eloubeidi M.A. Barrett's oesophagus: a review of costs of the illness. Pharmacoeconomics 19 (2001) 1003-1011
12. Inadomi J.M., Sampliner R., Lagergren J., et al. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med 138 (2003) 176-186
13. Shaheen N.J., Green B., Medapalli R.K., et al. The perception of cancer risk in patients with prevalent Barrett's esophagus enrolled in an endoscopic surveillance program. Gastroenterology 129 (2005) 429-436
14. Shaheen N.J., Dulai G.S., Ascher B., et al. Effect of a new diagnosis of Barrett's esophagus on insurance status. Am J Gastroenterol 100 (2005) 577-580